Podchaser Logo
Home
The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

Released Thursday, 29th June 2017
Good episode? Give it some love!
The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD

Thursday, 29th June 2017
Good episode? Give it some love!
Rate Episode

Today on Burning Issues Dr. Mitch is Joined by Julie Holland, M.D. Julie is a psychiatrist specializing in psychopharmacology, with a private practice in New York City. She majored in the Biological Basis of Behavior at the University of Pennsylvania and received her M.D. in 1992 from Temple University School of Medicine. At Mount Sinai Medical Center, she completed a residency program in psychiatry, where she created a research project that treated schizophrenics with a new medication. Together they talk about The evidence-base supporting the likelihood of safety and efficacy of cannabis for ADHD in adults and the need for definitive clinical trials. Also, Possible mechanism of action of THC, CBD etc in ADHD, including any basis in science for current working theory that cannabis provides focus through retrograde inhibition of GABA to create more Dopamine Transporter.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features